Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments

BACKGROUND: Distal renal tubular acidosis (dRTA), due to impaired acid secretion in the urine, can lead to severe long-term consequences. Standard of care (SoC) oral alkalizers, requiring several daily intakes, are currently used to restore normal plasma bicarbonate levels. A new prolonged-release f...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertholet-Thomas, Aurélia, Guittet, Catherine, Manso-Silván, Maria A., Castang, Arnaud, Baudouin, Véronique, Cailliez, Mathilde, Di Maio, Massimo, Gillion-Boyer, Olivia, Golubovic, Emilija, Harambat, Jérôme, Klein, Alexandre, Knebelmann, Bertrand, Nobili, François, Novo, Robert, Podracka, Ludmila, Roussey-Kesler, Gwenaëlle, Stylianou, Christos, Granier, Luc-André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701073/
https://www.ncbi.nlm.nih.gov/pubmed/32712761
http://dx.doi.org/10.1007/s00467-020-04693-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701073/
https://www.ncbi.nlm.nih.gov/pubmed/32712761
http://dx.doi.org/10.1007/s00467-020-04693-2

Ejemplares similares